Teladoc (TDOC) Chief Legal Officer Adam Vandervoort Sells Shares

What Happened
Adam C. Vandervoort, Chief Legal Officer and Secretary of Teladoc Health (TDOC), had 14,928 restricted/performance stock units convert to common shares on 2026-09-01 and those converted shares were used to satisfy tax withholding. He then sold 7,573 TDOC shares in an open-market transaction on 2026-09-02 at $6.30 per share, generating $47,717 in proceeds.

Key Details

• Transactions: Conversion/exercise of derivatives (code M) on 2026-09-01: 5,350 | 9,152 | 426 shares (total 14,928) converted to common stock one-for-one (F1, F2) and reported as disposed at $0 to cover tax withholding (F3). Open-market sale (code S) on 2026-09-02: 7,573 shares @ $6.30 = $47,717.
• Footnotes: F1–F2 confirm RSUs/PSUs convert one-for-one; F3 states shares sold to cover tax withholding; F4–F6 describe original grants and vesting schedules related to these awards.
• Shares owned after the transactions: not specified in the filing.
• Filing timeliness: report filed 2026-09-03 for transactions on 9/1–9/2; no late filing indicated.

Context

• Code explanations: M = exercise/conversion of derivative awards (here, RSUs/PSUs vesting into common stock); S = open-market sale.
• The converted shares were largely surrendered to satisfy tax obligations (a routine tax-withholding disposal), and a separate portion was sold in the open market. These actions are administrative/compensatory in nature rather than an outright new purchase.